Epigral Limited (NSE:EPIGRAL)

Market Cap	50.52B -38.7%
Revenue (ttm)	24.19B -1.2%
Net Income	3.38B -2.9%
EPS	78.35 -5.8%
Shares Out	43.14M
PE Ratio	14.95
Forward PE	16.87
Dividend	7.00 (0.60%)
Ex-Dividend Date	n/a

Volume	49,573
Average Volume	97,589
Open	1,171.05
Previous Close	1,171.00
Day's Range	1,166.05 - 1,210.00
52-Week Range	807.00 - 2,114.00
Beta	-0.24
RSI	74.32
Earnings Date	Apr 23, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc...

• Industry: Chemicals
• Sector: Materials
• Founded: 2007
• Employees: 1,072
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EPIGRAL

Financial Performance

In fiscal year 2025, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.